Script exchanges together
November 23, 2012
FRED IT’s eRx Script Exchange is
set to become linked to rival
MediSecure, with the government
providing almost $10 million in
funding to make the systems
interoperable.
According to an application
revealed by the Australian
Competition and Consumer
Commission, the so-called
‘Electronic Transfer of Prescription
(ETP) Prescription Exchange Service
Interoperability Initiative’ aims to
“significantly improve the uptake
and use of electronic prescriptions”.
E-prescribing is a significant policy
component of the Fifth Community
Pharmacy Agreement, and
according to early analysis there
are large numbers of electronic
prescriptions being lodged by
prescribers “but the number being
downloaded by dispensers is quite
low” - due to patients presenting to
a pharmacy which is not connected
to the prescription exchange
containing the e-script.
The project aims to allow
electronic prescriptions to be
accessed by all pharmacies,
regardless of which exchange the
script was lodged with.
eRx and MediSecure are now
tasked with working together and
sharing all information necessary to
create interoperability between
their systems, with a deadline in
the document of 24 Dec 2012 for
the work to be completed.
The companies will each receive
$660,000 (a total of $1.32m) as a
capital contribution to undertake
the work, which will also include
the standardisation of the format
and positioning of the barcodes on
the original prescriptions.
A further $8.3 million is being
made available to eRx and
MediSecure as a ‘PES Electronic
Prescription Fee (PEPF)’ which will
see 85c paid to an exchange per
eligible electronic prescription
downloaded and dispensed from
01 Jul 2012 to 31 Dec 2012, and 35c
per each e-script dispensed from 01
Jan-30 Jun 2013 until the full
amount is expended.
Payments will be made for
prescriptions which have been
assessed and completed for
claiming by Medicare, with the
schedule taking into account the
delay of up to three months in the
claim process.
The overall amount of $8.3m is
available for access by both script
exchanges and cannot be exceeded,
the agreement between FRED and
the government states.
The ACCC application for cartel
authorisation is necessary because
under the proposed collaboration,
eRx and MediSecure will “share
equally in the fee which is charged
to a pharmacy user and the
Commonwealth” by the exchange
to which the pharmacy is connected.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Nov 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Nov 12